0001246360-12-002890.txt : 20120629 0001246360-12-002890.hdr.sgml : 20120629 20120629175510 ACCESSION NUMBER: 0001246360-12-002890 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120627 FILED AS OF DATE: 20120629 DATE AS OF CHANGE: 20120629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS STEPHEN CENTRAL INDEX KEY: 0001131146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 12937004 MAIL ADDRESS: STREET 1: NEUROGEN CORP STREET 2: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 4 1 form.xml PRIMARY DOCUMENT X0305 4 2012-06-27 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001131146 DAVIS STEPHEN 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421 true false false false Stock Option (Right to Buy) 40.74 2012-06-27 4 A false 7500 0 A 2022-06-27 Common Stock 7500 7500 D 1/12 of the shares subject to this option vest and become exercisable on July 27, 2012 and monthly thereafter. /s/ Marc A. Rubenstein, Attorney-in-Fact 2012-06-29